Available Groups
id | 1921446642858389505 |
Melanoma, FDA approved, authoritative certification, Laos Daxiong Pharmaceutical Bimetinib MEKTODX 15mg 84 tablets/box
Indications:
15mg*84 tablets/box
Encofenib combined with bimetinib is used to treat patients with unresectable or metastatic melanoma detected by FDA-approved detection methods as BRAFV600E or V600K mutations.
Recommended dose: {For reference only, follow the doctor's advice}
Take 45 mg orally once a day, combined with Encofenib. Can be taken with food or alone.
Indications: Combined with the treatment of patients with BRAFV600E or V600K mutation-positive melanoma that cannot be removed or metastasized. Combined with the treatment of non-small cell lung cancer (NSCLC) with BRAFV600E mutations